ACH-3422 - Alexion Pharma, J&J
odalasvir (ACH-3102) - Alexion Pharma, J&J
Achillion: Cowen & Company Healthcare Conference (Achillion) - Mar 8, 2014 - Anticipated initiation of P2 ACH-3422 + ACH-3102 +/- ACH-PI (triple regimen) trial in hep C infection in early 2015 
Anticipated new P2 trial • Hepatitis C Virus
http://wsw.com/webcast/cowen16/register.aspx?conf=cowen16&page=achn&url=http%3A//wsw.com/webcast/cowen16/ACHN/
 
Mar 8, 2014
 
.